A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA

Modern Pathology

Volumn 27, Issue 9, 2014, Pages 1296-1305

  Villabona, Lisa ^a   Rodriguez, Daniel A Leon ^a,b   Andersson, Emilia K ^a   Seliger, Barbara ^c   Dalianis, Tina ^a   Masucci, Giuseppe V ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c Institute of Medical Immunology   (Germany)

Author keywords

Formalin fixed paraffin embedded tissue; HLA typing; Ovarian cancer sequencing

Indexed keywords

DNA; FORMALDEHYDE; HLA A ANTIGEN; PARAFFIN; FIXATIVE; PRIMER DNA;

ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA FINGERPRINTING; DNA POLYMORPHISM; EXON; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HLA TYPING; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; GENETICS; HISTOCOMPATIBILITY TEST; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; POLYMERASE CHAIN REACTION; PROCEDURES;

ALLELES; BASE SEQUENCE; DNA; DNA PRIMERS; EXONS; FEMALE; FIXATIVES; FORMALDEHYDE; GENE AMPLIFICATION; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION;

EID: 84925229006     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.210     Document Type: Article

References (25)

1. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 1999;401:921-923.
2. Goldsby RA, Kindt TJ, Osborne BA, et al. Immunology, 5th edn. W. H. Freeman: New York, NY, USA, 2003; chapt 7, 161-182.
3. Little AM, Stern PL. Does HLA type predispose some individuals to cancer? Mol Med Today 1999;8:337-342.
4. Little AM, Parham P. Polymorphism and evolution of HLA class I and II genes and molecules. Rev Immunogenet 1999;1:105-123.
5. Howell WM, Carter V, Clark B. The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques. J Clin Pathol 2010;63:387-390.
6. Gamzatova Z, Villabona L, Dahlgren L, et al. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer. Gynecol Oncol 2006;103:145-150.
7. Andersson E, Villabona L, Bergfeldt K, et al. Correlation of HLA-A02∗ genotype and HLA class I antigen downregulation with the prognosis of epithelial ovarian cancer. Cancer Immunol Immunother 2012;61:1243-1253.
8. De Petris L, Bergfeldt K, Hising C, et al. Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates. Med Oncol 2004;21:49-52.
9. Cannistra SA. Cancer of the ovary. N Engl J Med 2004;351:2519-2529.
10. Klopfleisch R, Weiss AT, Gruber AD. Excavation of a buried treasure - DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol 2011;26:797-810.
11. Gilbert MT, Sanchez JJ, Haselkorn T, et al. Multiplex PCR with minisequencing as an effective high-throughput SNP typing method for formalin-fixed tissue. Electrophoresis 2007;28:2361-2367.
12. Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 2001;25:409-418.
13. Farrugia A, Keyser C, Ludes B. Efficiency evaluation of a DNA extraction and purification protocol on archival formalin-fixed and paraffin-embedded tissue. Forensic Sci Int 2010;194:e25-e28.
14. Robinson J, Mistry K, McWilliam H, et al. The IMGT/HLA database. Nucleic Acids Res 2011;39(Database issue):D1171-D1176.
15. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
16. Fairley JA, Gilmour K, Walsh K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. Curr Drug Targets 2012;13:1475-1487.
17. Hewitt SM, Lewis FA, Cao Y, et al. Tissue handling and specimen preparation in surgical pathology. Arch Pathol Lab Med 2008;132:1929-1935.
18. Adams SD, Barracchini KC, Chen D, et al. Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification. J Transl Med 2004;2:30-36.
19. Soussi T. Advances in carcinogenesis: a historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis. Biochim Biophys Acta 2011;1816:199-208.
20. Turashvili G, Yang W, McKinney S, et al. Nucleic acid quantity and quality from paraffin blocks: Defining optimal fixation, processing and DNA/RNA extraction techniques. Exp Mol Pathol 2012;92:33-43.
21. Wilfinger WW, Mackey K, Chomczynski P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 1997;22:474-476; 478-81.
22. Bateman AC, Hemmatpour SK, Theaker JM, et al. Nested polymerase chain reaction-based HLA class II typing for the unique identification of formalin-fixed and paraffin-embedded tissue. J Pathol 1997;181:228-234.
23. Lee AH, Bateman AC, Turner SJ, et al. HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast. J Clin Pathol 1999;52:445-449.
24. Ota M, Shimada K, Asamura H, et al. Highly sensitive HLA-DNA typing from formalin-fixed and paraffin-embedded tissue samples. Am J Forensic Med Pathol 2006;27:347-351.
25. Bateman AC, Hemmatpour SK, Theaker JM, et al. Genetic analysis of hydatidiform moles in paraffin wax embedded tissue using rapid, sequence specific PCR-based HLA class II typing. J Clin Pathol 1997;50:288-293.